Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study-Reference-Cited by-同舟云学术

Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

Published:2013-07-27 Issue:6 Volume:27 Page:573-579
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

García-González Martín J., ,de Mora-Martín Manuel,López-Fernández Silvia,López-Díaz Javier,Martínez-Sellés Manuel,Romero-García José,Cordero Marco,Lara-Padrón Antonio,Marrero-Rodríguez Francisco,del Mar García-Saiz M.,Aldea-Perona Ana

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-013-6476-7.pdf

Reference33 articles.

1. Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J. 2001;22:623–6.

2. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002;4:531–9.

3. Anguita Sánchez M, Crespo Leiro MG, De Teresa GE, Jiménez Navarro M, Alonso-Pulpón L, Muñiz García J, et al. Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE study. Rev Esp Cardiol. 2008;61:1041–9.

4. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.

5. Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH, et al. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007;9:684–94.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights;International Journal of Molecular Sciences;2024-01-26

2. Use of Inotropic Agents in Advanced Heart Failure: Pros and Cons;Cardiology;2024-01-18

3. A favorable alliance between repetitive use of levosimendan and advanced heart failure: Polish two-centered inpatient perspective in need of validation;Kardiologia Polska;2023-03-27

4. Repetitive Therapie mit Levosimendan reduziert NT-proBNP und verbessert NYHA-Klasse;Aktuelle Kardiologie;2022-10

5. Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction;Drugs;2022-02-03